SWM
CELG

SeaCrest Wealth Management’s Celgene Corp CELG Stock Holding History

SeaCrest Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,007
Closed -$398K – 598
2019
Q3 		$398K Sell
4,007
-292
-7% -$27.7K 0.07% 320
2019
Q2 		$397K Sell
4,299
-151
-3% -$14.3K 0.08% 303
2019
Q1 		$420K Sell
4,450
-101
-2% -$8.83K 0.07% 280
2018
Q4 		$292K Sell
4,551
-2,505
-36% -$185K 0.06% 337
2018
Q3 		$631K Sell
7,056
-772
-10% -$68.2K 0.11% 204
2018
Q2 		$622K Sell
7,828
-174
-2% -$14.4K 0.11% 195
2018
Q1 		$714K Buy
8,002
+3,224
+67% +$309K 0.13% 158
2017
Q4 		$499K Buy
+4,778
New +$539K 0.09% 242

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

SeaCrest Wealth Management's CELG Position: Q4 2019 in Review

SeaCrest Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,007 shares — an estimated $398K sold.

SeaCrest Wealth Management first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $714K in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • SeaCrest Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • SeaCrest Wealth Management sold 4,007 Celgene Corp shares in Q4 2019, an estimated $398K.
  • SeaCrest Wealth Management first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • SeaCrest Wealth Management's Celgene Corp position peaked at $714K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SeaCrest Wealth Management's 13F filing for Q4 2019, filed 22 Jan 2020.